CLINICAL AND PROCEDURAL PREDICTORS OF SUBOPTIMAL TIMI FLOW IN PATIENTS OF STEMI UNDERGOING PRIMARY PCI

Authors

  • Asma Shabbir Rawalpindi Institute of Cradiology
  • Sana Ahmed Rawalpindi Institute of Cardiology
  • Muhammad Abdus Salam Azad RIC
  • Atif Nazir Rawalpindi Institute of Cardiology
  • Muhammad Kashif Rawalpindi Institute of Cardiology
  • Asim Javed Rawalpindi Institute of Cardiology

Keywords:

slow/no-reflow, Primary PCI

Abstract

Background: There is a high incidence of slow flow in patients of STEMI undergoing Primary PCI. Several etiologies have been proposed for mechanism of slow flow. However, there is no definitive treatment for slow flow. In our article we intend to study both clinical and procedural parameters associated with slow flow so as to highlight which factors are modifiable. Methods: This cross-sectional study conducted at RIC, where all patients presenting with STEMI who underwent PPCI were included. Both clinical and procedural parameters were documented for all patients. Patients were followed for inhospital mortality. Results: A total of 1029 patients were included in this study, 29.3% of the study population developed slow flow. 25.7% of smokers developing slow flow. Similarly, 55.6% of patients with ejection fraction of less than 30% and 41.5% of population above 70years of age developing slow flow. Patients in whom thrombuster was used initially to aspirate thrombus 31.8% of them developed slow flow whereas patients who underwent balloon dilatation initially 28.3% of them developed slow flow. Direct stenting was done in 20 patients out of which 9 patients developed slow flow. Stent length of greater than 35 mm was significantly associated with slow flow. Conclusion: Clinical factors female gender, advanced age, low EF and smoking were associated with slow flow, however amongst procedural predictors only stent length of greater than 35 mm was a significant predictor and only modifiable factor of suboptimal TIMI flow.

References

1. Annibali G, Scrocca I, Aranzulla TC, Meliga E, Maiellaro F, Musumeci G. "No-reflow" phenomenon: a contemporary review. J Clin Med 2022;11(8):2233.

2. Tasar O, Karabay AK, Oduncu V, Kirma C. Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coron Artery Dis 2019;30(4):270–6.

3. Alidoosti M, Lotfi R, Lotfi-Tokaldany M, Nematipour E, Salarifar M, Poorhosseini H, et al. Correlates of the "no-reflow" or "slow-flow" phenomenon in patients undergoing primary percutaneous coronary intervention. J Tehran Heart Cent 2018;13(3):108–14.

4. Montone RA, Camilli M, Del Buono MG, Meucci MC, Gurgoglione F, Russo M, et al. “No-reflow”: update su diagnosi, fisiopatologia e strategie terapeutiche [No-reflow: update on diagnosis, pathophysiology and therapeutic strategies]. G Ital Cardiol (Rome) 2020;21(6 Suppl 1):4S–14.

5. Ramjane K, Han L, Jin C. The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention. Exp Clin Cardiol 2008;13(3):121–8.

6. Ndrepepa G, Tiroch K, Fusaro M, Keta D, Byrne RA, Mehilli J, et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 2010;55(21):2383–9.

7. Pantea-Roșan LR, Pantea VA, Bungau S, Tit DM, Behl T, Vesa CM, et al. No-reflow after PPCI—a predictor of short-term outcomes in STEMI patients. J Clin Med 2020;9(9):2956.

8. Wang X, Nie SP. The coronary slow flow phenomenon: characteristics, mechanisms and implications. Cardiovasc Diagn Ther 2011;1(1):37–43.

9. Şahin DY, Gür M, Elbasan Z, Kuloğlu O, Şeker T, Kivrak A, et al. SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention. Coron Artery Dis 2013;24(2):148–53.

10. Verdoia M, Gioscia R, Viola O, Brancati MF, Soldà PL, Rognoni A, et al. Impact of age on pre-procedural TIMI flow in STEMI patients undergoing primary percutaneous coronary intervention. J Cardiovasc Med (Hagerstown) 2023;24(9):631–6.

11. Caixeta A, Lansky AJ, Mehran R, Brener SJ, Claessen B, Généreux P, et al. Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial. EuroIntervention 2013;9(2):220–7.

12. Lee CH, Teo SG, Hong E, Wong HB, Low A, Sutandar A, et al. Impact of glycemic control on occurrence of no-reflow and 30-day outcomes in diabetic patients undergoing primary angioplasty for myocardial infarction. J Invasive Cardiol 2005;17(8):422–6.

13. Ge J, Schäfer A, Ertl G, Nordbeck P. Thrombus aspiration for ST-segment-elevation myocardial infarction in modern era: still an issue of debate? Circ Cardiovasc Interv 2017;10(10):e005739.

14. Mangiacapra F, Sticchi A, Barbato E. Thrombus aspiration in primary percutaneous coronary intervention: still a valid option with improved technique in selected patients! Cardiovasc Diagn Ther 2017;7(Suppl 2):S110–4.

15. Chen Y, Gao YF, Wang YF, Wang CJ, Du Y, Ding YH. Influence of stent length on periprocedural outcomes after primary percutaneous coronary intervention in patients with ST segment elevation myocardial infarction. Clin Interv Aging 2022;17:1687–95.

16. Choo EH, Kim PJ, Chang K, Ahn Y, Jeon DS, Lee JM, et al. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality. Coron Artery Dis 2014;25(5):392–8.

Published

2026-05-21

How to Cite

1.
Shabbir A, Sana Ahmed, Muhammad Abdus Salam Azad, Atif Nazir, Muhammad Kashif, Asim Javed. CLINICAL AND PROCEDURAL PREDICTORS OF SUBOPTIMAL TIMI FLOW IN PATIENTS OF STEMI UNDERGOING PRIMARY PCI. J Ayub Med Coll Abbottabad [Internet]. 2026 May 21 [cited 2026 May 22];37(4). Available from: https://jamc.ayubmed.edu.pk/index.php/jamc/article/view/14209

Issue

Vol. 37 No. 4 (2025): 37-4

Section

ORIGINAL ARTICLE

License

Copyright (c) 2026 Asma Shabbir, Sana Ahmed, Muhammad Abdus Salam Azad, Atif Nazir, Muhammad Kashif, Asim Javed

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License  CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.

USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.

AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.